Pfizer, Bristol-Myers Blood Thinner Bests Warfarin for Study
Posted by admin in GeneralTags: businessweek, bristol myers squibb, pfizer inc, study, warfarin, apixaban, bristol myers squibb co, experimental blood, bristolmyers, bristol myersPfizer, Bristol-Myers Blood Thinner Bests Warfarin for Study
Pfizer Inc. and Bristol-Myers Squibb Co. said their experimental blood thinner apixaban was superior to standard therapy with warfarin and caused less bleeding in patients at risk of stroke because of an irregular heartbeat, sending shares higher in extended trading.
Read more on BusinessWeek
Comments Off
Entries (RSS)